Acetylcholine esterase levels in different clinical types of vitiligo in Baroda, Gujarat

Indian Journal of Dermatology

Volumn 51, Issue 4, 2006, Pages 289-291

  Shajil, E ^a   Marfatia, Y ^b   Begum, Rasheedunnisa ^a  

^a M S UNIVERSITY OF BARODA   (India)

^b Baroda Medical College   (India)

Author keywords

Acetylcholine esterase; Clinical types; Neural hypothesis; Vitiligo

Indexed keywords

EID: 33846672237     PISSN: 00195154     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5154.30299     Document Type: Article

References (19)

1. Mosher DB, Fitzpatrick TB, Ortonne JP, Hori TB, Hypomelnosis Y. In: Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Kats SI, Fitzpatrick TB. Dermatology in General Medicine. Mc Graw Hill: New York; 1999. p. 945-1017.
2. Handa S, Kaur I. Vitiligo: Clinical findings in 1436 patients. J Dermatol 1999;26:653-7.
3. Valia AK, Dutta PK. IADVL Text book and Atlas of Dermatology. Bhalani Publishing House: New York; 1996. p. 500-86.
4. Shajil EM, Chatterjee S, Agrawal D, Bagchi T, Begum R. Vitiligo: Pathomechanisms and genetic polymorphism of susceptible genes. Indian J Exp Biol 2006;44:526-39.
5. Hann SK, Nordlund JJ. Clinical features of generalized vitiligo. In: Hann SK, Nordlund JJ, editors. Vitiligo a monograph on the basic and clinical science. Blackwell Science: 2000. p. 35-48.
6. Taieb A. Intrinsic and extrinsic pathomechanisms in vitiligo. Pigment Cell Res 2000;13:41-7.
7. Ortonne JP, Bose SK. Vitiligo: Where do we stand? Pigment Cell Res 1993;6:61-72.
8. Agrawal D, Sahani MH, Gupta S, Begum R. Vitiligo etiopathogenesis and therapy - A Review. J Mah Sayajirao Univ Baroda 2001;48:97-106.
9. Agrawal D, Shajil EM, Marfatia YS, Begum R. Study on the antioxidant status of vitiligo patients of different age groups in Baroda. Pigment Cell Res 2004;17:289- 94.
10. Yildirim M, Baysal V, Inaloz HS, Kesici D, Delibas N. The role of oxidants and antioxidants in generalized vitiligo. J Dermatol 2003;2:104-8.
11. Boisseau-Garsaud P, Lejoly-Boissaeu H, Robert M, Quist D, Arveiler B. Increase in the total antioxidant status and selenium levels in the black patients with active vitiligo. Int J Dermatol 2002;10:640-2.
12. Reiner E, Sinko G, Skrinjaric-Spoljar M, Simeon-Rudolf V. Comparison of protocols for measuring activities of human blood cholinesterases by Ellman Mehotd. Arth Hig Rada Toksikol 2000;51:13-8.
13. Reedy MV, Parichy DM, Erickson CA, Mason KA, Frost-Mason SK. Regulation of melanoblasts migration and differentiation. In: Nordlund JJ, Boissey RE, Hearing VJ, King RA, Ortonne JP, editors. The Pigmentary system. Physiology and pathophysiology. Oxford University Press: New York; 1998. p. 75-95.
14. Koga M. Vitiligo: A new classification and therapy. Br J Dermatol 1997;97:255-61.
15. Iyengar B. Modulation of melanocytic activity by acetylcholine. Acta Anat (Basel) 1989;136:139-41.
16. Elwary SM, Headley K, Schallreuter KU. Calcium homeostasis influences epidermal sweating in patients with vitiligo. Br J Dermatol 1997;137:81-5.
17. 2: More evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun 2004;315:502-8.
18. Agrawal D. Antioxidant status of vitiligo patients relative to controls, M. Phil Dissertation. M.S. University of Baroda: Vadodara; 2002.
19. Shajil EM, Begum R. Antioxidant status of segmental and nonsegmental vitiligo. Pigment Cell Res 2006;19:179-80.